Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2003 1
2004 2
2005 3
2006 2
2008 2
2009 6
2010 4
2011 10
2012 8
2013 10
2014 7
2015 6
2016 11
2017 12
2018 7
2019 13
2020 15
2021 24
2022 15
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

141 results
Results by year
Filters applied: . Clear all
Page 1
Immunological Aspects of Approved MS Therapeutics.
Rommer PS, Milo R, Han MH, Satyanarayan S, Sellner J, Hauer L, Illes Z, Warnke C, Laurent S, Weber MS, Zhang Y, Stuve O. Rommer PS, et al. Among authors: warnke c. Front Immunol. 2019 Jul 11;10:1564. doi: 10.3389/fimmu.2019.01564. eCollection 2019. Front Immunol. 2019. PMID: 31354720 Free PMC article. Review.
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Ostkamp P, Salmen A, Pignolet B, Görlich D, Andlauer TFM, Schulte-Mecklenbeck A, Gonzalez-Escamilla G, Bucciarelli F, Gennero I, Breuer J, Antony G, Schneider-Hohendorf T, Mykicki N, Bayas A, Then Bergh F, Bittner S, Hartung HP, Friese MA, Linker RA, Luessi F, Lehmann-Horn K, Mühlau M, Paul F, Stangel M, Tackenberg B, Tumani H, Warnke C, Weber F, Wildemann B, Zettl UK, Ziemann U, Müller-Myhsok B, Kümpfel T, Klotz L, Meuth SG, Zipp F, Hemmer B, Hohlfeld R, Brassat D, Gold R, Gross CC, Lukas C, Groppa S, Loser K, Wiendl H, Schwab N; German Competence Network Multiple Sclerosis (KKNMS) and the BIONAT Network. Ostkamp P, et al. Among authors: warnke c. Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):e2018457118. doi: 10.1073/pnas.2018457118. Proc Natl Acad Sci U S A. 2021. PMID: 33376202 Free PMC article.
[Progressive multifocal leukoencephalopathy].
Warnke C, Wattjes MP, Adams O, Hartung HP, Martin R, Weber T, Stangel M. Warnke C, et al. Nervenarzt. 2016 Dec;87(12):1300-1304. doi: 10.1007/s00115-016-0225-7. Nervenarzt. 2016. PMID: 27730274 Review. German.
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy.
Möhn N, Grote-Levi L, Hopfner F, Eiz-Vesper B, Maecker-Kolhoff B, Warnke C, Sühs KW, Wattjes MP, Höglinger GU, Skripuletz T. Möhn N, et al. Among authors: warnke c. J Neurol. 2022 May;269(5):2403-2413. doi: 10.1007/s00415-021-10952-5. Epub 2022 Jan 7. J Neurol. 2022. PMID: 34994851 Free PMC article. Review.
Managing Risks with Immune Therapies in Multiple Sclerosis.
Förster M, Küry P, Aktas O, Warnke C, Havla J, Hohlfeld R, Mares J, Hartung HP, Kremer D. Förster M, et al. Among authors: warnke c. Drug Saf. 2019 May;42(5):633-647. doi: 10.1007/s40264-018-0782-8. Drug Saf. 2019. PMID: 30607830 Review.
141 results